|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 2070 |
FusionGeneSummary for AP2B1_RAB20 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AP2B1_RAB20 | Fusion gene ID: 2070 | Hgene | Tgene | Gene symbol | AP2B1 | RAB20 | Gene ID | 163 | 55647 |
| Gene name | adaptor related protein complex 2 subunit beta 1 | RAB20, member RAS oncogene family | |
| Synonyms | ADTB2|AP105B|AP2-BETA|CLAPB1 | - | |
| Cytomap | 17q12 | 13q34 | |
| Type of gene | protein-coding | protein-coding | |
| Description | AP-2 complex subunit betaadapter-related protein complex 2 beta subunitadapter-related protein complex 2 subunit betaadaptin, beta 2 (beta)adaptor protein complex AP-2 subunit betaadaptor related protein complex 2 beta 1 subunitadaptor-related prote | ras-related protein Rab-20 | |
| Modification date | 20180522 | 20180523 | |
| UniProtAcc | P63010 | Q9NX57 | |
| Ensembl transtripts involved in fusion gene | ENST00000262325, ENST00000592545, ENST00000538556, ENST00000312678, ENST00000589344, ENST00000537622, ENST00000545922, | ENST00000267328, | |
| Fusion gene scores | * DoF score | 7 X 7 X 4=196 | 3 X 1 X 3=9 |
| # samples | 7 | 3 | |
| ** MAII score | log2(7/196*10)=-1.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: AP2B1 [Title/Abstract] AND RAB20 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | HNSC | TCGA-CQ-6225-01A | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| In-frame | ENST00000262325 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| In-frame | ENST00000592545 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| 5UTR-3CDS | ENST00000538556 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| In-frame | ENST00000312678 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| In-frame | ENST00000589344 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| In-frame | ENST00000537622 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
| intron-3CDS | ENST00000545922 | ENST00000267328 | AP2B1 | chr17 | 33921086 | + | RAB20 | chr13 | 111176544 | - |
Top |
FusionProtFeatures for AP2B1_RAB20 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AP2B1 | RAB20 |
| Component of the adaptor protein complex 2 (AP-2).Adaptor protein complexes function in protein transport viatransport vesicles in different membrane traffic pathways. Adaptorprotein complexes are vesicle coat components and appear to beinvolved in cargo selection and vesicle formation. AP-2 isinvolved in clathrin-dependent endocytosis in which cargo proteinsare incorporated into vesicles surrounded by clathrin (clathrin-coated vesicles, CCVs) which are destined for fusion with theearly endosome. The clathrin lattice serves as a mechanicalscaffold but is itself unable to bind directly to membranecomponents. Clathrin-associated adaptor protein (AP) complexeswhich can bind directly to both the clathrin lattice and to thelipid and protein components of membranes are considered to be themajor clathrin adaptors contributing the CCV formation. AP-2 alsoserves as a cargo receptor to selectively sort the membraneproteins involved in receptor-mediated endocytosis. AP-2 seems toplay a role in the recycling of synaptic vesicle membranes fromthe presynaptic surface. AP-2 recognizes Y-X-X-[FILMV] (Y-X-X-Phi)and [ED]-X-X-X-L-[LI] endocytosis signal motifs within thecytosolic tails of transmembrane cargo molecules. AP-2 may alsoplay a role in maintaining normal post-endocytic traffickingthrough the ARF6-regulated, non-clathrin pathway. The AP-2 betasubunit acts via its C-terminal appendage domain as a scaffoldingplatform for endocytic accessory proteins; at least some clathrin-associated sorting proteins (CLASPs) are recognized by their [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif. The AP-2 beta subunit binds toclathrin heavy chain, promoting clathrin lattice assembly;clathrin displaces at least some CLASPs from AP2B1 which probablythen can be positioned for further coat assembly.{ECO:0000269|PubMed:14745134, ECO:0000269|PubMed:14985334,ECO:0000269|PubMed:15473838, ECO:0000269|PubMed:19033387}. | Plays a role in apical endocytosis/recycling. Plays arole in the maturation and acidification of phagosomes that engulfpathogens, such as S.aureus and M.tuberculosis. Plays a role inthe fusion of phagosomes with lysosomes.{ECO:0000269|PubMed:21255211}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | >RAB20 | chr17:33921086 | chr13:111176544 | ENST00000267328 | - | 0 | 2 | 113_116 | 57 | 235 | Nucleotide binding | GTP |
| Tgene | >RAB20 | chr17:33921086 | chr13:111176544 | ENST00000267328 | - | 0 | 2 | 55_59 | 57 | 235 | Nucleotide binding | GTP |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | >AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000262325 | + | 2 | 21 | 576_716 | 12 | 938 | Compositional bias | Note=Pro-rich (stalk region) |
| Hgene | >AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000312678 | + | 2 | 22 | 576_716 | 12 | 952 | Compositional bias | Note=Pro-rich (stalk region) |
| Hgene | >AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000537622 | + | 2 | 22 | 576_716 | 12 | 952 | Compositional bias | Note=Pro-rich (stalk region) |
| Hgene | >AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000538556 | + | 2 | 22 | 576_716 | -74 | 881 | Compositional bias | Note=Pro-rich (stalk region) |
| Hgene | >AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000589344 | + | 2 | 22 | 576_716 | 12 | 952 | Compositional bias | Note=Pro-rich (stalk region) |
| Tgene | RAB20 | chr17:33921086 | chr13:111176544 | ENST00000267328 | - | 0 | 2 | 33_41 | 57 | 235 | Motif | Effector region |
| Tgene | RAB20 | chr17:33921086 | chr13:111176544 | ENST00000267328 | - | 0 | 2 | 12_19 | 57 | 235 | Nucleotide binding | GTP |
Top |
FusionGeneSequence for AP2B1_RAB20 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| >In-frame_AP2B1_ENST00000262325_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_190aa MTDSKYFTTNKKGREQFHGLGSMYCRGAAAIILTYDVNHRQSLVELEDRFLGLTDTASKDCLFAIVGNKVDLTEEGALAGQEKEECSPNM DAGDRVSPRAPKQVQLEDAVALYKKILKYKMLDEQDVPAAEQMCFETSAKTGYNVDLLFETLFDLVVPMILQQRAERPSHTVDISSHKPP >In-frame_AP2B1_ENST00000592545_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_190aa MTDSKYFTTNKKGREQFHGLGSMYCRGAAAIILTYDVNHRQSLVELEDRFLGLTDTASKDCLFAIVGNKVDLTEEGALAGQEKEECSPNM DAGDRVSPRAPKQVQLEDAVALYKKILKYKMLDEQDVPAAEQMCFETSAKTGYNVDLLFETLFDLVVPMILQQRAERPSHTVDISSHKPP >In-frame_AP2B1_ENST00000312678_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_190aa MTDSKYFTTNKKGREQFHGLGSMYCRGAAAIILTYDVNHRQSLVELEDRFLGLTDTASKDCLFAIVGNKVDLTEEGALAGQEKEECSPNM DAGDRVSPRAPKQVQLEDAVALYKKILKYKMLDEQDVPAAEQMCFETSAKTGYNVDLLFETLFDLVVPMILQQRAERPSHTVDISSHKPP >In-frame_AP2B1_ENST00000589344_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_190aa MTDSKYFTTNKKGREQFHGLGSMYCRGAAAIILTYDVNHRQSLVELEDRFLGLTDTASKDCLFAIVGNKVDLTEEGALAGQEKEECSPNM DAGDRVSPRAPKQVQLEDAVALYKKILKYKMLDEQDVPAAEQMCFETSAKTGYNVDLLFETLFDLVVPMILQQRAERPSHTVDISSHKPP >In-frame_AP2B1_ENST00000537622_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_190aa MTDSKYFTTNKKGREQFHGLGSMYCRGAAAIILTYDVNHRQSLVELEDRFLGLTDTASKDCLFAIVGNKVDLTEEGALAGQEKEECSPNM DAGDRVSPRAPKQVQLEDAVALYKKILKYKMLDEQDVPAAEQMCFETSAKTGYNVDLLFETLFDLVVPMILQQRAERPSHTVDISSHKPP |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| >In-frame_AP2B1_ENST00000262325_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_570nt ATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCC ATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGAC TGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATG GACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAG ATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAG ACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCC >In-frame_AP2B1_ENST00000592545_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_570nt ATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCC ATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGAC TGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATG GACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAG ATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAG ACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCC >In-frame_AP2B1_ENST00000312678_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_570nt ATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCC ATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGAC TGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATG GACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAG ATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAG ACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCC >In-frame_AP2B1_ENST00000589344_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_570nt ATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCC ATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGAC TGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATG GACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAG ATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAG ACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCC >In-frame_AP2B1_ENST00000537622_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_570nt ATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCC ATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGAC TGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATG GACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAG ATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAG ACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCC |
| * Fusion transcript sequences (Full-length transcript). |
| >In-frame_AP2B1_ENST00000262325_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_1718nt TTTTACGTGCAGCACTATCCTCTAGCCCCACTGCCCGTATATAGGCCTGGGCTATATCACCATTGTCCGCCCTTGAGCCTGGAAGGAAAA TGAGCTGAGGGGTTTTGTTTTTTCAGAAAGGAACAGGATATTTCATCATCTCTATGTTTACGTTTTTCAGAGAATTTCTGTGCGAGGAAA CAAATCCATTGTCAGCTTTTTAAAATATATCCCTTTGGAGTAGCCACTTAACATCCTCTGAGGCCCAGATGGGCTAGCTTGCCGGGACCA AAGGAAATCTTTGGGTCTGGAAGGCGACAAGAGATCACAGGCTTTCTAGGTCTACCGCGCACCCCGATGACGTCACGCGGCGACGTTCTC TGACGTCAGAGTTTCCTGCCCACCATCTTTGTCCCTGGCAAAGTGGGTTTTGCGCAGTGGCTTAGACCTAGAAAAGAATCGTGACGGGCA GGAAACCATTACACCACCACCTGGGCTGTGCTCTCCGGCTCCCGCCGCCACCCCCGCCCTCGCCTTCGCCTCCGCCTCCGGTGCACATTA AAGATCCAAAGTCATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCG GGGGGCGGCCGCCATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACAC AGCCAGCAAAGACTGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTG CAGTCCCAATATGGACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGAT CCTCAAGTACAAGATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGA CCTCCTGTTTGAGACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAG TCATAAGCCACCCAAGAGGACCAGATCTGGGTGTTGTGCCTGACTTTCGAGGGCCTCCTGGACTCAGACTGTGCATGTTGGGAAGGGGTC TGACCAGGCAAGCTGTGATCTGAAAGGAGCAAGGAACAGCAAGGAATTATTTTCCAGAATGACACCCGCAGCAGAATGTTGGAGTGGAAA TGATGGCTGGCTATGAAGAGGAGGTCAACGTGTGTGGTCTCCTCAGTCTCTGTCAGAGGGGTGGGGAGGTGGGAAACAGGAATCCTCTGC AAAGCCCAATCTGCAGAGTCGAGACCCCTGGTGCTCTCTGCCCCGCTGCCTGGCACTGGTCCTTTGCAGCCAGCCACCAACGGCCCCCTT GCCCTTGCAGAGGCAGAAGCCTGCGTCTGCACCTGCACCTCTGACCGTTTCAGCACCCTGGGTTGTTACCACGTCCTACAACTCTGACAT TTCTTGTTCTCAAGCGTTTCTCTTCACTGTGAGTTGTCTTTGGTCCTCCCACTTGGTACTTGTATCTTGATGCTTTATAATCCTGACTCT CGACGTGTTCATTTATACAAAATCAGGAATAACTTTGTTTTTATACTGATTGCAGCAATGTTGGCTACATGTATTATTAAAGAGGATTTT >In-frame_AP2B1_ENST00000592545_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_1303nt AGTGGCTTAGACCTAGAAAAGAATCGTGACGGGCAGGAAACCATTACACCACCACCTGGGCTGTGCTCTCCGGCTCCCGCCGCCACCCCC GCCCTCGCCTTCGCCTCCGCCTCCGGTGCACATTAAAGATCCAAAGTCATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGG GAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCCATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTG GAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGACTGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAG GAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATGGACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTG CAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAGATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGC TTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAGACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGA GCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCCAAGAGGACCAGATCTGGGTGTTGTGCCTGACTTTCGAGGGCC TCCTGGACTCAGACTGTGCATGTTGGGAAGGGGTCTGACCAGGCAAGCTGTGATCTGAAAGGAGCAAGGAACAGCAAGGAATTATTTTCC AGAATGACACCCGCAGCAGAATGTTGGAGTGGAAATGATGGCTGGCTATGAAGAGGAGGTCAACGTGTGTGGTCTCCTCAGTCTCTGTCA GAGGGGTGGGGAGGTGGGAAACAGGAATCCTCTGCAAAGCCCAATCTGCAGAGTCGAGACCCCTGGTGCTCTCTGCCCCGCTGCCTGGCA CTGGTCCTTTGCAGCCAGCCACCAACGGCCCCCTTGCCCTTGCAGAGGCAGAAGCCTGCGTCTGCACCTGCACCTCTGACCGTTTCAGCA CCCTGGGTTGTTACCACGTCCTACAACTCTGACATTTCTTGTTCTCAAGCGTTTCTCTTCACTGTGAGTTGTCTTTGGTCCTCCCACTTG GTACTTGTATCTTGATGCTTTATAATCCTGACTCTCGACGTGTTCATTTATACAAAATCAGGAATAACTTTGTTTTTATACTGATTGCAG >In-frame_AP2B1_ENST00000312678_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_1295nt AGACCTAGAAAAGAATCGTGACGGGCAGGAAACCATTACACCACCACCTGGGCTGTGCTCTCCGGCTCCCGCCGCCACCCCCGCCCTCGC CTTCGCCTCCGCCTCCGGTGCACATTAAAGATCCAAAGTCATGACTGACTCCAAGTATTTCACAACCAATAAAAAAGGGCGGGAGCAGTT CCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCCATCATCCTCACCTATGATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGA GGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGACTGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCTCACTGAGGAGGGGGC CTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATGGACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGA GGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAGATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGAC CAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAGACCCTCTTTGACCTGGTGGTGCCAATGATCTTACAGCAGAGAGCTGAGAG GCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCCAAGAGGACCAGATCTGGGTGTTGTGCCTGACTTTCGAGGGCCTCCTGGAC TCAGACTGTGCATGTTGGGAAGGGGTCTGACCAGGCAAGCTGTGATCTGAAAGGAGCAAGGAACAGCAAGGAATTATTTTCCAGAATGAC ACCCGCAGCAGAATGTTGGAGTGGAAATGATGGCTGGCTATGAAGAGGAGGTCAACGTGTGTGGTCTCCTCAGTCTCTGTCAGAGGGGTG GGGAGGTGGGAAACAGGAATCCTCTGCAAAGCCCAATCTGCAGAGTCGAGACCCCTGGTGCTCTCTGCCCCGCTGCCTGGCACTGGTCCT TTGCAGCCAGCCACCAACGGCCCCCTTGCCCTTGCAGAGGCAGAAGCCTGCGTCTGCACCTGCACCTCTGACCGTTTCAGCACCCTGGGT TGTTACCACGTCCTACAACTCTGACATTTCTTGTTCTCAAGCGTTTCTCTTCACTGTGAGTTGTCTTTGGTCCTCCCACTTGGTACTTGT ATCTTGATGCTTTATAATCCTGACTCTCGACGTGTTCATTTATACAAAATCAGGAATAACTTTGTTTTTATACTGATTGCAGCAATGTTG >In-frame_AP2B1_ENST00000589344_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_1419nt ACCTGGGCTGTGCTCTCCGGCTCCCGCCGCCACCCCCGCCCTCGCCTTCGCCTCCGCCTCCGGTGAGTTCAGGGCGGTTGCCTTTAGGGT GTGTCCCTAATTGACGGGGTCGGGGACGGAGAGAAGGGTAACACCAGGCTGGGTCGGAGACCGGCGGAGGCGAGGAAATCCTAAGAGCGT GACCGTTGATGATGCAGGGAACCGTCGGGTGTGACCATTGAGAGGGAAAAGGTGCACATTAAAGATCCAAAGTCATGACTGACTCCAAGT ATTTCACAACCAATAAAAAAGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCCATCATCCTCACCTATG ATGTGAATCACCGGCAGAGCCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGACTGCCTCTTTGCCATCG TGGGGAACAAAGTGGACCTCACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATGGACGCTGGGGACCGTG TCTCCCCAAGGGCACCTAAGCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAGATGCTGGATGAGCAGG ATGTGCCGGCCGCTGAGCAAATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAGACCCTCTTTGACCTGG TGGTGCCAATGATCTTACAGCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCCAAGAGGACCAGATCTG GGTGTTGTGCCTGACTTTCGAGGGCCTCCTGGACTCAGACTGTGCATGTTGGGAAGGGGTCTGACCAGGCAAGCTGTGATCTGAAAGGAG CAAGGAACAGCAAGGAATTATTTTCCAGAATGACACCCGCAGCAGAATGTTGGAGTGGAAATGATGGCTGGCTATGAAGAGGAGGTCAAC GTGTGTGGTCTCCTCAGTCTCTGTCAGAGGGGTGGGGAGGTGGGAAACAGGAATCCTCTGCAAAGCCCAATCTGCAGAGTCGAGACCCCT GGTGCTCTCTGCCCCGCTGCCTGGCACTGGTCCTTTGCAGCCAGCCACCAACGGCCCCCTTGCCCTTGCAGAGGCAGAAGCCTGCGTCTG CACCTGCACCTCTGACCGTTTCAGCACCCTGGGTTGTTACCACGTCCTACAACTCTGACATTTCTTGTTCTCAAGCGTTTCTCTTCACTG TGAGTTGTCTTTGGTCCTCCCACTTGGTACTTGTATCTTGATGCTTTATAATCCTGACTCTCGACGTGTTCATTTATACAAAATCAGGAA >In-frame_AP2B1_ENST00000537622_chr17_33921086_+_RAB20_ENST00000267328_chr13_111176544_-_1400nt AGGGTGTGTCCCTAATTGACGGGGTCGGGGACGGAGAGAAGGGTAACACCAGGCTGGGTCGGAGACCGGCGGAGGCGAGGAAATCCTAAG AGCGTGACCGTTGATGATGCAGGGAACCGTCGGGTGTGACCATTGAGAGGGAAAAGGTTGGAGAAAGGGTCTCTACCATGATGCCTGTGG TGCGGTGAGGGAATCCTCGGGTGTGGCAGCAGGTGCACATTAAAGATCCAAAGTCATGACTGACTCCAAGTATTTCACAACCAATAAAAA AGGGCGGGAGCAGTTCCACGGCCTGGGCTCCATGTACTGCCGGGGGGCGGCCGCCATCATCCTCACCTATGATGTGAATCACCGGCAGAG CCTGGTGGAGCTGGAGGACCGGTTCCTGGGCCTGACAGACACAGCCAGCAAAGACTGCCTCTTTGCCATCGTGGGGAACAAAGTGGACCT CACTGAGGAGGGGGCCTTGGCGGGCCAGGAGAAGGAAGAGTGCAGTCCCAATATGGACGCTGGGGACCGTGTCTCCCCAAGGGCACCTAA GCAGGTGCAGCTGGAGGATGCGGTGGCCCTTTATAAAAAGATCCTCAAGTACAAGATGCTGGATGAGCAGGATGTGCCGGCCGCTGAGCA AATGTGCTTTGAGACCAGCGCCAAGACCGGCTACAATGTGGACCTCCTGTTTGAGACCCTCTTTGACCTGGTGGTGCCAATGATCTTACA GCAGAGAGCTGAGAGGCCGTCACACACAGTGGATATATCCAGTCATAAGCCACCCAAGAGGACCAGATCTGGGTGTTGTGCCTGACTTTC GAGGGCCTCCTGGACTCAGACTGTGCATGTTGGGAAGGGGTCTGACCAGGCAAGCTGTGATCTGAAAGGAGCAAGGAACAGCAAGGAATT ATTTTCCAGAATGACACCCGCAGCAGAATGTTGGAGTGGAAATGATGGCTGGCTATGAAGAGGAGGTCAACGTGTGTGGTCTCCTCAGTC TCTGTCAGAGGGGTGGGGAGGTGGGAAACAGGAATCCTCTGCAAAGCCCAATCTGCAGAGTCGAGACCCCTGGTGCTCTCTGCCCCGCTG CCTGGCACTGGTCCTTTGCAGCCAGCCACCAACGGCCCCCTTGCCCTTGCAGAGGCAGAAGCCTGCGTCTGCACCTGCACCTCTGACCGT TTCAGCACCCTGGGTTGTTACCACGTCCTACAACTCTGACATTTCTTGTTCTCAAGCGTTTCTCTTCACTGTGAGTTGTCTTTGGTCCTC CCACTTGGTACTTGTATCTTGATGCTTTATAATCCTGACTCTCGACGTGTTCATTTATACAAAATCAGGAATAACTTTGTTTTTATACTG |
Top |
FusionGenePPI for AP2B1_RAB20 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| AP2B1 | KIAA0408, DHX58, MLH1, AP1M1, MEA1, TUBGCP4, LDLRAP1, THAP1, POM121, NECAP2, ATP6V1G1, NUP54, TERF2IP, FAM46C, RIBC2, AP1M2, AP2M1, RNPS1, TGFBR1, TGFBR2, BUB1B, CLINT1, ARRB2, OSBPL10, APC, ITSN1, SIRT7, CLTC, AMPH, CUL3, ABL1, SHC1, CRK, EPS15, ERBB2, FN1, VCAM1, DAB2, ITGA4, MMS19, RNF11, EGFR, GRB2, PLOD2, EPN1, LNPEP, NUSAP1, SEC24C, XPO7, RPA3, RPA2, RPA1, EPHA2, GTF2I, PIP5K1C, SLC25A6, KPNA2, U2AF1, RAPGEF3, TXN2, AFF4, XRCC6BP1, NEU4, AAK1, HSPB1, AP1S1, AP1S2, AP1G1, AP2A1, AP2A2, CAB39, AP2S1, COX5B, NUP50, TOMM40, VAPA, NTRK1, CEP128, ODF2, XPO1, CLTB, DBN1, FLNA, GAK, MYH9, PICALM, LIMA1, GTSE1, ANLN, MYO19, TFRC, MCM2, MEX3C, TFAP2A, DIEXF, MYO6, ARFGAP1, RUNDC3A, SNX9, UBC, OCRL, TRIM25, BRCA1, SLC2A8 | RAB20 | NXF1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Hgene | AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000262325 | + | 2 | 21 | 841_937 | 12 | 938 | ARRB1 |
| Hgene | AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000312678 | + | 2 | 22 | 841_937 | 12 | 952 | ARRB1 |
| Hgene | AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000537622 | + | 2 | 22 | 841_937 | 12 | 952 | ARRB1 |
| Hgene | AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000538556 | + | 2 | 22 | 841_937 | -74 | 881 | ARRB1 |
| Hgene | AP2B1 | chr17:33921086 | chr13:111176544 | ENST00000589344 | + | 2 | 22 | 841_937 | 12 | 952 | ARRB1 |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AP2B1_RAB20 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for AP2B1_RAB20 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | AP2B1 | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|